title: Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.
abstract: MicroRNA-26a (miR-26a) is a tumor suppressor that is reduced in hepatocellular carcinoma (HCC). Increasing evidence indicates that the liver is a hormone-responsive organ like the breast. The purpose of this study was to investigate whether miR-26a, regulated by a human α-fetoprotein (hAFP) and human telomerase reverse transcriptase (hTERT) dual promoter, could be specifically expressed in liver tumor cells to suppress their growth and to clarify whether estrogen receptor-α (ERα) is regulated by miR-26a and involved in the HCC process. Our data show that miR-26a expression driven by a hAFP-TERT dual promoter was tumor-specific and decreased the viability of tumor cells by regulating ERα, progesterone receptor (PR) and P53 except for cyclin D2 or cyclin E2 in vitro and in vivo. Our data also show that estradiol (E2) promotes the growth of liver cancer cells similar to breast cancer cells partly via the E2-ERα pathway and that miR-26a significantly down regulates ERα and prevents the stimulation of hepatoma cell growth by E2. These data suggest that ERα, which is regulated by miR-26a, is important for liver tumor cell growth. Moreover, hAFP-TERT dual promoter-mediated miR-26a expression could specifically exert potential antitumor activity and provide a novel targeting approach for cancer therapy.
authors: Clinical Research Centre, Changhai Hospital, Second Military Medical University, Shanghai, China.
authors: Lizao
authors: L
authors: Chen
authors: Jianming
authors: J
authors: Zheng
authors: Yan
authors: Y
authors: Zhang
authors: Luxi
authors: L
authors: Yang
authors: Jiaqi
authors: J
authors: Wang
authors: Jian
authors: J
authors: Ni
authors: Daxiang
authors: D
authors: Cui
authors: Chaoqin
authors: C
authors: Yu
authors: Zailong
authors: Z
authors: Cai
references: N Engl J Med. 2009 Oct 8;361(15):1437-47
references: 19812400
references: Hepatology. 2009 Aug;50(2):490-9
references: 19472311
references: J Gastrointestin Liver Dis. 2006 Mar;15(1):9-14
references: 16680226
references: Gene Ther. 2001 Jan;8(1):80-3
references: 11402306
references: Br J Cancer. 2005 Jan 31;92(2):252-8
references: 15668718
references: J Natl Cancer Inst. 2004 Mar 17;96(6):466-74
references: 15026472
references: Breast Cancer Res. 2005;7(1):R101-12
references: 15642158
references: Cancer Res. 1991 Aug 1;51(15):3867-73
references: 1855205
references: J Mol Endocrinol. 2005 Feb;34(1):77-89
references: 15691879
references: J Biomed Sci. 2008 May;15(3):343-55
references: 18183498
references: Cancer Cell. 2004 Mar;5(3):215-9
references: 15050913
references: Cancer Res. 1980 Oct;40(10):3680-5
references: 6108158
references: Hum Gene Ther. 1993 Oct;4(5):643-5
references: 8280802
references: J Hepatol. 2010 Jun;52(6):864-71
references: 20413175
references: Hepatology. 2009 Oct;50(4):1152-61
references: 19711427
references: Mol Endocrinol. 2007 Dec;21(12):2907-18
references: 17761946
references: Biochim Biophys Acta. 2010 May-Jun;1799(5-6):469-79
references: 20079471
references: Anticancer Res. 2003 Jul-Aug;23(4):3273-7
references: 12926063
references: Biomacromolecules. 2010 Oct 11;11(10):2667-74
references: 20815397
references: Br Med J. 1975 Nov 29;4(5995):496-8
references: 172187
references: J Clin Oncol. 2009 Dec 1;27(34):5734-42
references: 19805671
references: J Hepatol. 2010 May;52(5):698-704
references: 20347499
references: J Virol. 1995 Apr;69(4):2004-15
references: 7884845
references: Cell. 2005 Jan 14;120(1):15-20
references: 15652477
references: Cell. 2009 Jun 12;137(6):1005-17
references: 19524505
references: Gastroenterology. 2007 Jun;132(7):2557-76
references: 17570226
references: Dig Dis Sci. 1991 Sep;36(9):1303-8
references: 1654243
references: Cancer Lett. 2009 Dec 28;286(2):196-205
references: 19564073
references: Oncogene. 2005 Dec 8;24(55):8167-75
references: 16091743
references: J Hepatol. 1992 May;15(1-2):225-36
references: 1324273
references: J Surg Oncol Suppl. 1993;3:1-7
references: 7684910
references: Br J Surg. 1995 Apr;82(4):542-7
references: 7613907